|
Russell leads our pursuits to acquire additional near-term cancer drugs, form additional drug development alliances and explore commercialization options for the company's proprietary therapeutics such as Levofolinic Acid (LFA) and EOquin(tm). He is also responsible for global strategy, investor relations and fund raising.
Russell most recently served as Chief Financial Officer at Hana Biosciences, Inc. Previously, he was Chief Financial Officer and Portfolio Management Partner at Asset Management Company, one of Silicon Valley's oldest venture capital firms, Vice President at GE Capital Services' Structured Finance Group, and Director of Corporate Development at Pinkerton's, Inc. He has a Masters in Business Administration from the Stanford Graduate School of Business, preceded by a Bachelor of Arts degree in Economics from Claremont McKenna College. | 